Curanex Pharmaceuticals Inc (CURX) shareholders
CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$4.70+0.07 (+1.40%)
Close on Nov 17, 2026Market cap $7.37MP/E –Yield –
Ownership
Who owns Curanex Pharmaceuticals's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jun Liu | CEO and President, Director, 10% owner | 10,524,560 | 33.56% | Sep 2, 2025 |
| Huijuan Zhong | Chief Science Officer, Director | – | – | Sep 2, 2025 |
| Ning Zhang | Chief Technology Officer | – | – | Sep 2, 2025 |
| Dian Ying Jing | Secretary, 10% owner | 4,651,000 | 14.83% | Sep 2, 2025 |
| Liqin Xie | Chief Operating Officer | – | – | Sep 2, 2025 |
| Xiaohui Hao | Director | – | – | Sep 2, 2025 |
| Yong Yan | Director | – | – | Sep 2, 2025 |
| Helen Hong Hsu | Director | – | – | Sep 2, 2025 |
| Chang Liu | 10% owner | 7,982,220 | 25.45% | Sep 2, 2025 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
0.38%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
+14.4%
From 0M shares
Short volume, 20 days
20.0%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Curanex Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 3,181 shares on Sep 18, 2026 over the last 90 days.
See a number that looks wrong?